Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Pyxis Oncology, Inc. (PYXS) had Free Cash Flow per Share of $-0.37 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-21.16M |
|
-- |
|
-- |
|
$22.91M |
|
$-22.91M |
|
$1.76M |
|
$-21.16M |
|
$-21.16M |
|
$-21.16M |
|
$-21.16M |
|
$-21.16M |
|
$-21.16M |
|
$-22.91M |
|
$-23.52M |
|
61.05M |
|
61.05M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$111.87M |
|
$9.40M |
|
$24.00M |
|
$135.87M |
|
$14.43M |
|
-- |
|
$18.33M |
|
$32.76M |
|
$103.10M |
|
$100.56M |
|
$103.10M |
|
61.63M |
|
| Cash Flow Statement Financials | |
$-22.54M |
|
$15.82M |
|
$0.00M |
|
$20.95M |
|
$14.23M |
|
$-6.71M |
|
$3.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.52% |
|
-21.04% |
|
-15.57% |
|
-20.52% |
|
$1.67 |
|
|
Free Cash Flow per Share |
$-0.37 |
$-0.37 |
|